Mensa Futura Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 M
- Revenue Growth 13.53%
- Profit Growth 16.49%
- Ebitda 68.55%
- Net Worth 71.93%
- Total Assets 48.90%
About Mensa Futura Life Sciences
Mensa Futura Life Sciences Private Limited (MFLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 January 2018 (Seven years and one month 0 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.00 M.
Rajesh Bajaj, Anurag Bajaj, and Rajendra Kumar serve as directors at the Company.
Company Details
-
Location
Gurugram, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33119HR2018PTC072188
-
Company No.
072188
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jan 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Mensa Futura Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Bajaj
|
Director | 09-Jan-2018 | Current |
|
Anurag Bajaj
|
Director | 09-Jan-2018 | Current |
|
Rajendra Kumar
|
Director | 20-Apr-2018 | Current |
Financial Performance of Mensa Futura Life Sciences.
Mensa Futura Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.53% increase. The company also saw a substantial improvement in profitability, with a 16.49% increase in profit. The company's net worth Soared by an impressive increase of 71.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mensa Futura Life Sciences?
In 2023, Mensa Futura Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Curiv Lifecare Private LimitedRajesh Bajaj and Anurag Bajaj are mutual person
Charges (Loans)
₹6.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Sep 2024 | Others | ₹6.00 M | Open |
How Many Employees Work at Mensa Futura Life Sciences?
Unlock and access historical data on people associated with Mensa Futura Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mensa Futura Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mensa Futura Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
